Oncology Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . Oncology Institute
TOI Stock  USD 0.16  0.01  5.88%   
Oncology Institute financial statements provide useful quarterly and yearly information to potential Oncology Institute investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Oncology Institute financial statements helps investors assess Oncology Institute's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Oncology Institute's valuation are summarized below:
Gross Profit
52.1 M
Profit Margin
(0.20)
Market Capitalization
12.8 M
Enterprise Value Revenue
0.2317
Revenue
361.1 M
We have found one hundred twenty available trending fundamental ratios for Oncology Institute, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Oncology Institute recent fundamentals against the fundamentals between 2010 and 2024 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 142.9 M. Enterprise Value is estimated to decrease to about 224.8 M

Oncology Institute Total Revenue

226.56 Million

Check Oncology Institute financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncology Institute's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.8 M, Interest Expense of 7.1 M or Selling General Administrative of 121.1 M, as well as many indicators such as Price To Sales Ratio of 0.44, Dividend Yield of 0.0235 or PTB Ratio of 2.51. Oncology financial statements analysis is a perfect complement when working with Oncology Institute Valuation or Volatility modules.
  
Check out the analysis of Oncology Institute Correlation against competitors.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.

Oncology Institute Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding68.4 M73.7 M44.8 M
Slightly volatile
Total Assets176.4 M209.2 M100.9 M
Slightly volatile
Other Current Liabilities11.2 M13.5 M7 M
Slightly volatile
Total Current Liabilities30.1 M34.8 M19.3 M
Slightly volatile
Total Stockholder Equity78.4 M57 M54.3 M
Slightly volatile
Other Liabilities6.7 M7 M8.6 M
Slightly volatile
Property Plant And Equipment Net42.1 M40.1 M9.1 M
Slightly volatile
Accounts Payable13.4 M14.4 M10.3 M
Slightly volatile
Cash37.5 M33.5 M15.3 M
Slightly volatile
Non Current Assets Total70.9 M65.7 M48.8 M
Slightly volatile
Non Currrent Assets Other323.5 K561 K178.3 K
Slightly volatile
Other Assets279.8 K548.5 K181.8 K
Slightly volatile
Cash And Short Term Investments61.5 M82.9 M24.2 M
Slightly volatile
Net Receivables30 M42.9 M19.9 M
Slightly volatile
Good Will13.7 M7.2 M15.1 M
Pretty Stable
Liabilities And Stockholders Equity176.4 M209.2 M100.9 M
Slightly volatile
Non Current Liabilities Total67.9 M117.4 M27.3 M
Slightly volatile
Inventory8.3 M13.7 M5.4 M
Slightly volatile
Other Current Assets6.6 M8.1 M2.9 M
Slightly volatile
Other Stockholder Equity140.2 M203.2 M51.9 M
Slightly volatile
Total Liabilities98 M152.2 M46.6 M
Slightly volatile
Property Plant And Equipment Gross48.5 M46.2 M10.4 M
Slightly volatile
Total Current Assets105.5 M143.5 M52.1 M
Slightly volatile
Capital Stock7.6 K8 K37.4 M
Slightly volatile
Non Current Liabilities Other346.8 K365 K2.3 M
Pretty Stable
Net Working Capital75.5 M108.7 M32.8 M
Slightly volatile
Intangible Assets15.3 M17.9 M20.6 M
Slightly volatile
Common Stock6.3 K8 K2.7 K
Slightly volatile
Property Plant Equipment10.3 M9.8 M3.4 M
Slightly volatile
Short and Long Term Debt Total66 M119.7 M28.3 M
Slightly volatile
Current Deferred Revenue517.8 K545 K2.7 M
Slightly volatile
Long Term Debt63.8 M86.8 M25.6 M
Slightly volatile
Short and Long Term Debt156.5 K164.7 K4 M
Slightly volatile
Short Term Debt4.8 M6.4 M5.1 M
Pretty Stable
Warrants368 M414 M450.8 M
Slightly volatile
Common Stock Total Equity4.2 K8.1 K1.7 K
Slightly volatile
Capital Surpluse194.5 M214.2 M173.6 M
Slightly volatile

Oncology Institute Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.8 M5.9 M2.2 M
Slightly volatile
Interest Expense7.1 M6.8 M1.2 M
Slightly volatile
Selling General Administrative121.1 M115.3 M38 M
Slightly volatile
Total Revenue226.6 M324.2 M157.8 M
Slightly volatile
Gross Profit45 M59.6 M33.4 M
Slightly volatile
Other Operating Expenses263.4 M401.3 M171.1 M
Slightly volatile
Cost Of Revenue181.5 M264.7 M124.5 M
Slightly volatile
Total Operating Expenses81.9 M136.6 M46.7 M
Slightly volatile
Reconciled Depreciation3.8 M5.5 M2.2 M
Slightly volatile
Selling And Marketing Expenses33.3 M37.4 M40.8 M
Slightly volatile

Oncology Institute Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow25.2 M14 M10.9 M
Slightly volatile
Depreciation3.8 M5.9 M2.2 M
Slightly volatile
Capital Expenditures3 M4.6 M1.7 M
Slightly volatile
End Period Cash Flow31.4 M33.5 M13.5 M
Slightly volatile
Stock Based Compensation15.5 M17.8 M5.8 M
Slightly volatile
Cash Flows Other Operating6.9 M6.6 M1.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.440.4642.2779
Slightly volatile
Dividend Yield0.02350.02650.0288
Slightly volatile
PTB Ratio2.512.638312.2059
Slightly volatile
Days Sales Outstanding34.148.305537.2477
Slightly volatile
Book Value Per Share0.830.77320.7944
Slightly volatile
Average Payables8.6 M9.7 M10.5 M
Slightly volatile
Stock Based Compensation To Revenue0.04590.05490.0225
Slightly volatile
Capex To Depreciation0.580.77760.6659
Pretty Stable
PB Ratio2.512.638312.2059
Slightly volatile
EV To Sales0.690.72983.2262
Slightly volatile
Inventory Turnover29.2719.349830.177
Slightly volatile
Days Of Inventory On Hand11.5418.863312.3635
Slightly volatile
Payables Turnover12.1918.342614.3636
Pretty Stable
Sales General And Administrative To Revenue0.00130.00150.0016
Slightly volatile
Capex To Revenue0.00950.01410.0087
Slightly volatile
Cash Per Share0.641.12350.3323
Slightly volatile
Payout Ratio1.661.872.0355
Slightly volatile
Days Payables Outstanding28.2719.89925.9594
Very volatile
Intangibles To Total Assets0.110.12010.4789
Slightly volatile
Current Ratio2.614.12482.2238
Slightly volatile
Receivables Turnover9.857.55619.9695
Slightly volatile
Graham Number4.654.42681.5753
Slightly volatile
Shareholders Equity Per Share0.830.77320.7944
Slightly volatile
Debt To Equity1.61.52260.5627
Slightly volatile
Capex Per Share0.0330.06190.0316
Slightly volatile
Average Receivables12.8 M14.4 M15.7 M
Slightly volatile
Revenue Per Share2.734.39653.6445
Slightly volatile
Interest Debt Per Share1.331.26920.2652
Slightly volatile
Debt To Assets0.440.4150.2106
Slightly volatile
Operating Cycle45.6467.168749.6112
Slightly volatile
Price Book Value Ratio2.512.638312.2059
Slightly volatile
Days Of Payables Outstanding28.2719.89925.9594
Very volatile
Dividend Payout Ratio1.661.872.0355
Slightly volatile
Company Equity Multiplier1.843.66931.7342
Slightly volatile
Long Term Debt To Capitalization0.320.60360.2527
Slightly volatile
Total Debt To Capitalization0.630.60360.3271
Slightly volatile
Debt Equity Ratio1.61.52260.5627
Slightly volatile
Quick Ratio2.393.73161.9468
Slightly volatile
Net Income Per E B T1.120.99960.9155
Slightly volatile
Cash Ratio0.90.96260.5452
Slightly volatile
Cash Conversion Cycle25.0847.269824.1658
Slightly volatile
Days Of Inventory Outstanding11.5418.863312.3635
Slightly volatile
Days Of Sales Outstanding34.148.305537.2477
Slightly volatile
Price To Book Ratio2.512.638312.2059
Slightly volatile
Fixed Asset Turnover7.698.095577.5331
Slightly volatile
Debt Ratio0.440.4150.2106
Slightly volatile
Price Sales Ratio0.440.4642.2779
Slightly volatile
Asset Turnover1.971.54962.2959
Slightly volatile
Gross Profit Margin0.220.18370.2194
Slightly volatile
Price Fair Value2.512.638312.2059
Slightly volatile

Oncology Institute Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap142.9 M150.4 M529.9 M
Slightly volatile
Enterprise Value224.8 M236.6 M538.6 M
Slightly volatile

Oncology Fundamental Market Drivers

Cash And Short Term Investments82.9 M

Oncology Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Oncology Institute Financial Statements

Investors use fundamental indicators, such as Oncology Institute's revenue or net income, to determine how well the company is positioned to perform in the future. Although Oncology Institute's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue545 K517.8 K
Total Revenue324.2 M226.6 M
Cost Of Revenue264.7 M181.5 M
Stock Based Compensation To Revenue 0.05  0.05 
Capex To Revenue 0.01  0.01 
Revenue Per Share 4.40  2.73 
Ebit Per Revenue(0.24)(0.25)

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors
When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:
How To Invest In Oncology
Details
Is Oncology Stock a good investment?
Details
What is Oncology Institute's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Oncology Institute Correlation against competitors.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.77)
Revenue Per Share
4.873
Quarterly Revenue Growth
0.229
Return On Assets
(0.19)
Return On Equity
(1.26)
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY